Abstract: The present invention provides a method for treating a solution contaminated with porcine circovirus, comprising the steps of: adjusting a pH of a solution contaminated with porcine circovirus to range from 3.0 to 7.0; and treating the pH-adjusted solution with a filtration membrane having an LRV for bacteriophage PP7 of 4 or more.

Abstract: The present invention provides a cation-exchange chromatographic support, comprising a membrane matrix and a copolymer immobilized on the surface of the membrane matrix, wherein the copolymer comprises a (meth)acrylamide-based compound and/or a (meth)acrylate-based compound as monomer units, and the support has one or more species of cation-exchange groups including at least a weak cation-exchange group at a density higher than 30 mmol/L per volume of the support.

Abstract: A hollow fiber membrane module includes: a tubular container accommodating a hollow fiber membrane bundle; headers, and potted parts. The header includes a header protrusion that protrudes in an annular shape toward the tubular container. The tubular container includes double annular protrusions, which are an inner protrusion and an outer protrusion protruding toward the header. The header and the tubular container are welded together by ultrasonic welding, with the header protrusion being inserted between the inner protrusion and the outer protrusion of the tubular container. The header protrusion and the inner protrusion of the tubular container are welded together at least in one or more regions, and the header protrusion and the outer protrusion of the tubular container are welded together at least in one or more regions.

Abstract: The hollow fiber membrane module according to the present application is provided with a cylindrical container open at one end and the other end, a bundle of hollow fiber membranes packed in the cylindrical container, potting parts embedding and fixing the bundle of hollow fiber membranes at both ends of the cylindrical container, and headers provided at both ends of the cylindrical container and having nozzles that constitute an inlet and outlet for a fluid. In this hollow fiber membrane module, the headers and the cylindrical container are welded in at least two areas including a primary weld and a secondary weld, and the secondary weld is located in a position where welding is initiated after or simultaneously with the beginning of welding of the primary weld.

Abstract: The present invention provides a hollow-fiber membrane blood purification device obtained by filling a container with a hollow-fiber membrane, in which the hollow-fiber membrane contains a hydrophobic polymer, a hydrophilic polymer and a lipid-soluble substance; the amount of the lipid-soluble substance on the inner surface of the hollow-fiber membrane is 10 mg/m2 or more and 300 mg/m2 or less; and the oxygen transmission rate of the container is 1.8×10?10 cm3·cm/(cm2·s·cmHg) or less.

Abstract: A blood processing filter for removing undesirable components from liquid containing a blood component or blood, comprises: a sheet-shaped filter element; and a container that includes an inlet-side container element and an outlet-side container element that are disposed to clamp the filter element, and has an internal space separated by the filter element into an inlet space and an outlet space, wherein the filter element includes a filtering surface on a side of the inlet space, a filtering surface on a side of the outlet space, and an end surface along peripheries of the pair of filtering surfaces, and the inlet-side container element and the outlet-side container element are provided with a gripper, and the gripper clamps and compresses an outer edge portion of the pair of filtering surfaces, and is caused to adhere to the end surface with melt resin.

Abstract: Provided are an aggregate-removing filter material enabling the efficient removal of aggregates while preventing the clogging by the aggregates, an aggregate removal method, a white blood cell-removing filter, and a blood product filtering method. An aggregate-removing filter material for removing aggregates in a blood product, which is composed only of fibers having a fiber length of 100 to 1000 mm, and a fineness of 0.7 to 4.0 dtex, and has a basis weight of 20 to 100 g/m2, and a no-load bulk density of 0.03 to 0.10 g/cm3.

Abstract: A blood processing filter comprises an inlet-side flexible container and an outlet-side flexible container that sandwich a filter element, an inlet port, and an outlet port, the filter further comprising: a flow path securing sheet; a first seal portion; and a second seal portion, wherein the flow path securing sheet includes a pair of ribs disposed opposite to each other with the outlet port interposed therebetween, and a slit formed inside of the pair of ribs, and diffusing openings that are disposed outside of the pair of ribs and continuously open from the ribs to the lateral portions of the first seal portion.

Abstract: The present invention provides a method for purifying a protein, comprising: providing a solution containing a monomer and aggregates of the protein of interest; a purification step of removing the aggregates of the protein of interest using a cation-exchange chromatographic support media to obtain a purified solution of the monomer, the cation-exchange chromatographic support media comprising at least one type of weak cation-exchange group and having a cation-exchange group density higher than 30 mmol/L; and a virus removal step of removing viruses from the purified solution using a virus removal membrane having a virus logarithmic reduction value of 3 or more.

Abstract: Provided are a parvovirus derived from an unconcentrated cell culture supernatant, having a infectivity titer of 109 TCID50/mL or more and an {infectivity titer (TCID50/mL)}:{impurity protein concentration (ng/mL)} ratio more than 5000:1; and a method of producing such a high-infectivity titer and high-purity parvovirus.

Abstract: A ferrule coupling is easy to mount onto members to be coupled such as pipe conduits and apparatuses and can reliably maintain the sealability even when subjected to temperature rises and falls due to a sterilization process etc. A ferrule coupling has an annular male screw member which is provided on one of members to be coupled and has a thread formed on the outer peripheral surface, and an annular female screw member which is provided on the other of the members to be coupled and has a thread formed on the inner peripheral surface. The male screw member and the female screw member are screw-engaged with each other to thereby couple the members to be coupled with each other. The male screw member has a cut section at one part in the circumferential direction, and can be opened or closed such that the cut section widens or narrows.

Abstract: The present invention relates to a phosphate adsorbing agent for blood processing comprising a porous formed article comprising an organic polymer resin and an inorganic ion adsorbent and having the most frequent pore size of 0.08 to 0.70 ?m measured with a mercury porosimeter. The present invention also relates to a blood processing system and a blood processing method involving the phosphate adsorbing agent for blood processing.

Abstract: In the removal of white blood cells from blood, the efficiency of white blood cell removal by a filter is improved. Centrifugal force is applied to blood placed in a blood bag by centrifugal separation to form a plurality of separation layers having a concentration gradient of white blood cells. The separation layers are passed through a filter in ascending order of white blood cell concentration to remove the white blood cells from the separation layers. The separation layers from which the white blood cells have been removed are received in a first blood component bag.

Abstract: The present invention relates to a method for reducing a ?-amyloid concentration in blood. Specifically, the present invention relates to a method for reducing a ?-amyloid concentration in blood, comprising the steps of; removing blood out of a body, passing the blood that is removed through a hollow fiber membrane, and returning the blood that is passed through into the body, wherein the blood containing a ?-amyloid-albumin complex is passed through the hollow fiber membrane to allow ?-amyloid to adsorb to the hollow fiber membrane so that the ?-amyloid concentration in blood is reduced.

Abstract: A blood processing filter for removing undesirable components from liquid containing a blood component or blood, comprises: a sheet-shaped filter element; and a hard container that includes an inlet-side container element and an outlet-side container element that are disposed to clamp the filter element, and has an internal space separated by the filter element into an inlet space and an outlet space, wherein the filter element includes a filtering surface on a side of the inlet space, a filtering surface on a side of the outlet space, and an end surface along peripheries of the pair of filtering surfaces, the inlet-side container element and the outlet-side container element are provided with a gripper that clamps and compresses an outer edge portion of the pair of filtering surfaces, and a thickness of the filter element is compressed at the gripper to be 0.05 to 0.5 times the thickness.

Abstract: Disclosed is a hollow-fiber membrane blood purification device having an improved antioxidant performance, good water permeation performance and blood compatibility performance, and economic rationality. The present invention provides a hollow-fiber membrane blood purification device including hollow-fiber membranes filled in a vessel, in which the hollow-fiber membranes contain a hydrophobic polymer, a hydrophilic polymer and a fat-soluble vitamin, when a hollow-fiber membrane bundle is divided into five sections in a lengthwise direction and divided sections positioned in endmost portions are defined as body end portions, an amount of the fat-soluble vitamin present in at least one of the body end portions is the largest among amounts of the fat-soluble vitamin present respectively in all the divided sections, and an amount of the fat-soluble vitamin per m2 of a hollow-fiber membrane inner surface of the at least one body end portion is 20 mg/m2 or more and 300 mg/m2 or less.

Abstract: The present invention provides a filter element for a blood processing filter, comprising a nonwoven fabric, wherein the rebound strength per unit basis weight (g/m2) before steam heat treatment is 0.3 (N·m2/g) or larger.

Abstract: A separation membrane for blood processing, wherein the separation membrane for blood processing includes: a separation membrane containing polysulfone-based polymer and polyvinylpyrrolidone; and a coating film provided on at least a part of the surface of the separation membrane and containing a polymer material having a structure represented by the following general formula (1): wherein R1 is a hydrogen atom or a methyl group; R2 is a methyl group or an ethyl group; n is 2 to 6 and m is 1 to 3; P denotes the number of repetition; and a plurality of each of R1, R2, n, and m present in one molecule may be the same or different.

Abstract: The present invention provides a filter element for a blood processing filter, comprising a nonwoven fabric, wherein the quantity of crystallization heat of the uncrystallized portion of the nonwoven fabric is 5 J/g or smaller before steam heat treatment.

Abstract: The present invention provides a separation membrane for blood processing, comprising a polysulfone polymer, a hydrophilic polymer and a polymer having a hydroxy group in a side chain and having a solubility of 0.5 g or less in water (100 g) at 20° C., in which the content of the polymer falls within a specific range, and a blood processing apparatus having the membrane installed therein.